Target phospholipid covered fluorescent/nuclear magnetic dual-mode probe as well as preparation and application
A phospholipid-targeting, dual-modality technology, used in general/multifunctional contrast agents, preparations for in vivo experiments, pharmaceutical formulations, etc., can solve problems such as irreversible damage, and achieve stable properties, strong operability, Meet the effect of production and application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Dissolve the fluorescent (FITC) modified DSPE (FITC-DSPE), DSPE-PEG and the targeting DSPE (the sequence of the targeting peptide is CPVTRPPR) in 1 above in chloroform solution. Add zinc-doped Fe3O4 nanoparticles (Zn-Fe 3 O 4 ), making the phospholipids and Zn-Fe 3 O 4 The mass ratio is 2:1. Place the mixed solution in a round-bottomed flask, add an appropriate amount of Q water, and mix with ultrasound. Rotary evaporation of the above mixed solution at 70°C for 15 min. The zinc-doped ferroferric oxide nanoparticles are adsorbed on the bottom of the container by a magnet, and the supernatant is removed to remove the uncoated phospholipids, and finally a fluorescent / nuclear magnetic dual-mode probe coated with targeted phospholipids is obtained.
Embodiment 2
[0031] Dissolve the fluorescent (FITC) modified DSPE (FITC-DSPE), DSPE-PEG and the targeting DSPE (the sequence of the targeting peptide is CRPAKPAR) in 1 above in chloroform solution. Add zinc-doped Fe3O4 nanoparticles (Zn-Fe 3 O 4 ), making the phospholipids and Zn-Fe 3 O 4 The mass ratio is 3:1. Place the mixed solution in a round-bottomed flask, add an appropriate amount of Q water, and mix with ultrasound. Rotary evaporation of the above-mentioned mixed solution at 60°C for 20 min. The zinc-doped ferroferric oxide nanoparticles are adsorbed on the bottom of the container by a magnet, and the supernatant is removed to remove the uncoated phospholipids, and finally a fluorescent / nuclear magnetic dual-mode probe coated with targeted phospholipids is obtained.
Embodiment 3
[0033] Dissolve the fluorescent (FITC) modified DSPE (FITC-DSPE), DSPE-PEG and the targeted DSPE (the sequence of the targeting peptide is CRGERPPR) in the above 1 in 2.5 ml of chloroform solution. Add zinc-doped Fe3O4 nanoparticles (Zn-Fe 3 O 4 ) 2.5ml colloidal solution to make phospholipids and Zn-Fe 3 O 4 The mass ratio is 5:1. Place the mixed solution in a round bottom flask, add 5 ml of Q water, and mix well with ultrasound. Rotary evaporation of the above mixed solution at 80°C for 30 min. The zinc-doped ferroferric oxide nanoparticles are adsorbed on the bottom of the container by a magnet, and the supernatant is removed to remove the uncoated phospholipids, and finally a fluorescent / nuclear magnetic dual-mode probe coated with targeted phospholipids is obtained.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com